ZNF132 expression at the RNA level, consistent with its methylation status, is significantly lower in ESCC cells, indicating possible tumor suppressor function of ZNF132. These results have led us to further explore the clinical value of hypermethylation of ZNF132 promoter. Here, ZNF132 is linked to esophageal squamous cell carcinoma.